Apoa5 | ENSMUSG00000032079 | NCBI 66113

Details for: Apoa5

Gene ID: 66113

Symbol: Apoa5

Ensembl ID: ENSMUSG00000032079

Description: apolipoprotein A-V

Associated with

Chylomicron remodeling
(R-MMU-8963901)
Metabolism of proteins
(R-MMU-392499)
Plasma lipoprotein assembly, remodeling, and clearance
(R-MMU-174824)
Plasma lipoprotein remodeling
(R-MMU-8963899)
Post-translational protein modification
(R-MMU-597592)
Post-translational protein phosphorylation
(R-MMU-8957275)
Regulation of insulin-like growth factor (igf) transport and uptake by insulin-like growth factor binding proteins (igfbps)
(R-MMU-381426)
Transport of small molecules
(R-MMU-382551)
Acylglycerol homeostasis
(GO:0055090)
Cholesterol efflux
(GO:0033344)
Cholesterol homeostasis
(GO:0042632)
Cholesterol metabolic process
(GO:0008203)
Cholesterol transfer activity
(GO:0120020)
Chylomicron
(GO:0042627)
Cytosol
(GO:0005829)
Endosome
(GO:0005768)
Enzyme activator activity
(GO:0008047)
Enzyme binding
(GO:0019899)
Extracellular region
(GO:0005576)
Extracellular space
(GO:0005615)
Extracellular vesicle
(GO:1903561)
Golgi apparatus
(GO:0005794)
Heparin binding
(GO:0008201)
High-density lipoprotein particle
(GO:0034364)
Lipase activator activity
(GO:0060229)
Lipase binding
(GO:0035473)
Lipid binding
(GO:0008289)
Lipid transport
(GO:0006869)
Lipoprotein lipase activator activity
(GO:0060230)
Lipoprotein metabolic process
(GO:0042157)
Lipoprotein particle receptor binding
(GO:0070325)
Low-density lipoprotein particle receptor binding
(GO:0050750)
Phosphatidylcholine-sterol o-acyltransferase activator activity
(GO:0060228)
Phosphatidylcholine binding
(GO:0031210)
Phospholipid binding
(GO:0005543)
Phospholipid efflux
(GO:0033700)
Positive regulation of fatty acid biosynthetic process
(GO:0045723)
Positive regulation of lipid catabolic process
(GO:0050996)
Positive regulation of lipoprotein lipase activity
(GO:0051006)
Positive regulation of triglyceride catabolic process
(GO:0010898)
Positive regulation of very-low-density lipoprotein particle remodeling
(GO:0010902)
Triglyceride-rich lipoprotein particle remodeling
(GO:0034370)
Triglyceride catabolic process
(GO:0019433)
Triglyceride homeostasis
(GO:0070328)
Triglyceride metabolic process
(GO:0006641)
Very-low-density lipoprotein particle
(GO:0034361)

Other Information

Proteins

Apolipoprotein A-V

Genular Protein ID: 3879986916

Symbol: APOA5_MOUSE

Name: Apolipoprotein A-V

UniProtKB Accession Codes:

Q8C7G5 Q91X90 Q99P64

Database IDs:

Citations:

PubMed ID: 11577099

Title: Apolipoprotein A-V. A novel apolipoprotein associated with an early phase of liver regeneration.

PubMed ID: 11577099

DOI: 10.1074/jbc.m106888200

PubMed ID: 16141072

Title: The transcriptional landscape of the mammalian genome.

PubMed ID: 16141072

DOI: 10.1126/science.1112014

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 11588264

Title: An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing.

PubMed ID: 11588264

DOI: 10.1126/science.1064852

PubMed ID: 15090553

Title: ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.

PubMed ID: 15090553

DOI: 10.1074/jbc.m403240200

PubMed ID: 17242355

Title: Large-scale phosphorylation analysis of mouse liver.

PubMed ID: 17242355

DOI: 10.1073/pnas.0609836104

PubMed ID: 21183079

Title: A tissue-specific atlas of mouse protein phosphorylation and expression.

PubMed ID: 21183079

DOI: 10.1016/j.cell.2010.12.001

Sequence Information:

Length: 368
Mass: 41262
Checksum: B5B2F1982C47475B
Sequence:

MAAVITWALA LLAVFASTQA RKSLWDYFSQ NSWSKGVMGQ PQKLAQENLK GSFEQDLYNM 
NNYLEKLGPL RGPGKEPPLL AQDPEGIRKQ LQQELGEVSS RLEPYMAAKH QQVGWNLEGL 
RQQLKPYTAE LMEQVGLSVQ ELQEQLRVVG EDTKAQLLGG VDEALNLLQD MQSRVLHHTD 
RVKELFHPYA ERLVTGIGHH VQELHRSVAP HAAASPARLS RCVQTLSHKL TRKAKDLHTS 
IQRNLDQLRD ELSAFIRVST DGAEDGDSLD PQALSEEVRQ RLQAFRHDTY LQIAAFTQAI 
DQETEEIQHQ LAPPPPSHSA FAPELGHSDS NKALSRLQSR LDDLWEDIAY GLQDQGHSHL 
SDPEGHSG

The gene details are incomplete or unavailable at the moment.

Database document:

This is a preview of the gene's schema. Only a few entries are kept for 'singleCellExpressions,' 'mRNAExpressions,' and other large data arrays for visualization purposes. You can zoom in with the mouse wheel for a closer view, and the text will adjust automatically if necessary. For the full schema, download it here.

Details for: Apoa5

Associated with

Other Information

Apolipoprotein A-V. A novel apolipoprotein associated with an early phase of liver regeneration. PubMed ID: 11577099

The transcriptional landscape of the mammalian genome. PubMed ID: 16141072

The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). PubMed ID: 15489334

An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. PubMed ID: 11588264

ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. PubMed ID: 15090553

Large-scale phosphorylation analysis of mouse liver. PubMed ID: 17242355

A tissue-specific atlas of mouse protein phosphorylation and expression. PubMed ID: 21183079